Position in CRNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$41,349,023
+$18,534,435 QoQ
Shares Held
1,104,998
+75.9% QoQ
Ownership
1.04%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 264 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. CRNX ranks #77 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in CRNX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,349,023 | 1,104,998 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $22,814,588 | 628,155 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $26,399,760 | 567,127 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $29,701,863 | 713,130 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $25,909,509 | 900,887 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $16,756,382 | 499,594 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $36,878,483 | 721,269 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $40,217,130 | 787,028 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $29,077,219 | 649,190 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $40,448,848 | 864,107 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $23,133,155 | 650,173 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $16,434,263 | 552,598 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $11,079,524 | 614,846 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $8,354,379 | 520,198 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $2,439,682 | 133,316 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $2,409,198 | 122,668 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $1,817,498 | 97,453 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $2,427,735 | 110,603 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,747,782 | 61,520 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $1,166,695 | 55,425 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $1,146,173 | 60,805 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,869,538 | 122,352 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,808,648 | 128,182 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,588,812 | 101,392 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $246,033 | 14,043 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||